Clinical evaluation of 5-S-cysteinyldopa testing using a new and optimized detection system as a tumour marker for malignant melanoma. [electronic resource]
- Melanoma research Oct 2002
- 471-7 p. digital
Publication Type: Journal Article
0960-8931
10.1097/00008390-200209000-00009 doi
Biomarkers, Tumor Case-Control Studies Chromatography, High Pressure Liquid Cysteinyldopa--blood Disease Progression Female Humans Male Melanoma--blood Prognosis Sensitivity and Specificity